Why insider trading matters?

If management teams do not own any relevant stakes in the companies they guide, they may not be focused on creating wealth for shareholders to the same degree, compared to those that see their personal wealth increase when share prices rise.

- Klaus Gugler, Economist
Aimmune Therapeutics, Inc. (AIMT)
Sector: Healthcare; Industry: Biotechnology

Aimmune Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes product candidates for the treatment of peanut and other food allergies. Aimmune Therapeutics, Inc. has a strategic collaboration with an affiliate of Nestle Health Science US Holdings, Inc. for the advancement of food allergy therapeutics; and clinical collaboration agreement with Regeneron Ireland Unlimited Company and Sanofi Biotechnology SAS to study AR101 with adjunctive dupilumab in peanut-allergic patients in a Phase II trial. The company was formerly known as Allergen Research Corporation and changed its name to Aimmune Therapeutics, Inc. in May 2015.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2018-06-11 DILLY STEPHEN GEORGE President and CEO Sell 29,457 $30.83 $908,301 Yes
2018-06-08 DILLY STEPHEN GEORGE President and CEO Sell 105,169 $30.92 $3,251,993 Yes
2018-06-05 DILLY STEPHEN GEORGE See Remarks Sell 165,374 $32.14 $5,315,183 Yes
2017-10-23 DILLY STEPHEN GEORGE See Remarks Sell 100,000 $33.55 $3,354,538 No
2017-10-16 DILLY STEPHEN GEORGE President and CEO Sell 1,154 $26.24 $30,279 No
2017-10-06 DILLY STEPHEN GEORGE President and CEO Sell 98,846 $26.24 $2,593,317 No
2017-09-25 DILLY STEPHEN GEORGE President and CEO Sell 100,000 $25.01 $2,500,790 No
2017-07-26 DILLY STEPHEN GEORGE President and CEO Sell 50,000 $21.46 $1,073,110 No
2017-06-23 DILLY STEPHEN GEORGE President and CEO Sell 49,400 $20.21 $998,591 No
2017-05-10 DILLY STEPHEN GEORGE See Remarks Sell 600 $20.15 $12,090 No
2016-11-11 DILLY STEPHEN GEORGE See Remarks Sell 50,000 $25.01 $1,250,590 No

Insider Smart

PENN NATIONAL GAMING INC (PENN) - PENN took a deep dive from $36 to $5 due to the crash, anyone who was bold enough to pick up some shares in March or April could have made a 900% profit in 2 months. But bottom fishing is always easier said than done, if one took a safer bet and followed multiple insider buying around $18, a 100% profit is still impressive.